Table 3.
Aβ42/40 ratio < 0.068 | Aβ42/40 ratio ≥ 0.068 | |
---|---|---|
LL (n = 59) | 10 (17%)—IAP | 49 (83%)—LL |
IAP (n = 21) | 14 (67%)—IAP | 7 (33%)—LL |
SNAP (n = 55) | 36 (66%)—HL | 19 (34%)—SNAP |
HL (n = 62) | 56 (90%)—HL | 6 (10%)—SNAP |
Data expressed as n (percentage) of patients
Aβ42/40 42-aminoacid isoform of amyloid beta/40-aminoacid isoform of amyloid beta, LL Low-AD likelihood, IAP isolated amyloid pathology, SNAP suspected non-Alzheimer pathology, HL high-AD likelihood, AD Alzheimer’s disease